Track topics on Twitter Track topics that are important to you
Cureveda LLC was co-founded in 2010 by Johns Hopkins Bloomberg School of Public Health faculty members Shyam Biswal and Rajesh Thimmulappa together with Christy Wyskiel. The company is focused on the discovery, development and commercialization of drugs for the treatment of inflammatory, autoimmune and neurogenerative diseases. Cureveda is developing Nrf2 activators for the treatment of a number of disease indications including chronic obstructive pulmonary disorder, multiple sclerosis and ulcerative colitis. The Company is also developing Nrf2 activators as medical countermeasures to treat radiation exposure. For further information, please visit the Cureveda website at www.cureveda.com.
Cureveda LLC was co-founded in 2010 by Johns Hopkins Bloomberg School of Public Health faculty members Shyam Biswal and Rajesh Thimmulappa together with Christy Wyskiel. The compa...
We have published hundreds of Cureveda LLC news stories on BioPortfolio along with dozens of Cureveda LLC Clinical Trials and PubMed Articles about Cureveda LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cureveda LLC Companies in our database. You can also find out about relevant Cureveda LLC Drugs and Medications on this site too.
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...